Join FDA Commissioner Stephen M. Hahn, M.D. and Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D. for their final episode of FDA Insight as they discuss FDA’s Pandemic Recovery and Preparedness Plan, or PREPP. After this episode, the program is scheduled to go on hiatus.

FDA Insight

Pandemic Recovery and Preparedness Plan (PREPP)

Frank Yiannas, FDA’s Deputy Commissioner for Food Policy and Response, joins Dr. Shah for a discussion on the New Era of Smarter Food Safety and how its blueprint impacts FDA’s COVID-19 response.

New Era of Smarter Food Safety

Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its contribution to fighting COVID-19.

Compounded Drugs

Dr. Jeffrey C. Baker, Deputy Director of the FDA’s Office of Biotechnology Products in the Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on how FDA’s efforts help innovation and implementation of Advanced Manufacturing technologies regarding food and drug safety.

Advanced Manufacturing

Dr. Anand Shah and Rear Adm. Richardae Araojo, Associate Commissioner of Minority Health, discuss the FDA’s efforts to address minority health disparities among diverse racial and ethnic populations.

Minority Health and Health Equity

Dr. Shah welcomes Dr. Janet Maynard, director of FDA’s Office of Orphan Products Development, for a discussion on the agency’s work advancing evaluation and development of products that demonstrate promise for the diagnosis and treatment of rare diseases.

Rare Diseases and Orphan Products

Dr. Shah welcomes Dr. Suzanne Schwartz, director of FDA’s Office of Strategic Partnerships and Technology Innovation at the Center for Devices and Radiological Health, for a discussion on personal protective equipment and its critical role in helping to reduce the spread of COVID-19.

Personal Protective Equipment and COVID-19

Dr. Shah welcomes Elizabeth Jungman, director of CDER’s Office of Regulatory Policy, to talk about hand sanitizers and the COVID-19 pandemic.

Hand Hygiene During COVID-19

On this week's episode, Dr. Shah brings Dr. Peter Marks back to the show to discuss the importance of getting the flu vaccine. For more information about the flu vaccine, visit: https://www.fda.gov/flu

Get Your Flu Vaccine

Dr. Peter Marks, FDA's Director of the Center for Biologics Evaluation and Research, returns for his third episode to provide an update on COVID-19 vaccines and to discuss the upcoming Vaccines and Related Biological Products Advisory Committee meeting.

Advisory Committee on COVID-19 Vaccines

Dr. Kaveeta Vasisht, FDA's Associate Commissioner for Women's Health, joins FDA Insight to discuss the Office of Women's Health's work to advance the health of women through scientific programs, policy development, research, education and outreach.

An Insight into Women’s Health

Dr. Shah welcomes Dr. Steve Solomon, Director of FDA's Center for Veterinary Medicine, to discuss the work CVM is doing in combating antimicrobial resistance.

Anti-Microbial Resistance

Dr. Shah welcomes Dr. Susan Mayne, Director of FDA's Center for Food Safety and Applied Nutrition, to discuss nutrition and chronic disease prevention, including health disparities.

A Closer Look at Nutrition

Mitch Zeller, Director of FDA's Center for Tobacco Products, joins Dr. Shah in a discussion on e-cigarettes (or vapes) and the 2020 National Youth Tobacco Survey results. For more on how you can stop using tobacco products, go to https://everytrycounts.gov.

E-Cigarettes and the National Youth Tobacco Survey

Dr. Shah welcomes Megan Moncur, FDA’s Associate Director of Opioid Policy, to the show to discuss the opioid epidemic and how it’s been impacted by the COVID-19 pandemic.

The Opioid Epidemic and COVID-19 Pandemic

Join FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics. The program will be on hiatus starting Jan. 20, 2021.

hubhopper

FDA Insight

hubhopper